Skip to main content

Table 1 Characteristics of the study sample

From: Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study

 

Total sample (#349)

EA (#65)

NEA (#284)

p

CD(#155)

NCD (#194)

p

Age at conception (mean, SD, years)

31.8 (4.7)

32.5 (4.7)

31.7 (4.7)

0.232

31.7 (4.7)

31.8 (4.7)

0.907

Age at onset (mean, SD, years)

24.7 (5.8)

24.6 (6.4)

24.8 (5.7)

0.860

24.5 (6.0)

24.8 (5.7)

0.550

Disease duration at conception (mean, SD, years)

7.1 (4.8)

7.8 (5.9)

6.97 (4.5)

0.279

7.27 (4.8)

7.0 (4.8)

0.689

EDSS at conception (mean, SD)

1.5 (1.0)

1.5 (0.97)

1.5 (0.98)

0.868

1.6 (1.0)

1.4 (0.92)

0.107

Treated with DMDs before pregnancy (#, %)

176 (50.4)

28 (43.1%)

147 (51.8)

0.226

87 (56.1)

89 (45.9)

0.057

Relapses in the year prior to pregnancy (mean, SD)

0.4 (0.7)

0.37 (0.6)

0.39 (0.7)

0.800

0.38 (0.73)

0.39 (0.7)

0.937

Relapses during pregnancy (mean, SD)

0.12 (0.4)

0.1 (0.3)

0.11 (0.3)

0.950

0.15 (0.42)

0.09 (0.29)

0.157

Relapses in the year after the delivery (mean, SD)

0.45 (0.7)

0.35 (0.57)

0.48 (0.76)

0.130

0.47 (0.8)

0.44 (0.67)

0.677

Exclusive breastfeeding (#,%)

162 (46.4)

19 (29.2)

99 (34.9)

0.370

47 (30.3)

71 (36.6)

0.316

  1. EA: epidural analgesia.
  2. NEA: Not epidural analgesia.
  3. CD: caesarean delivery.
  4. NCD: not caesarean delivery.
  5. SD: Standard Deviation.
  6. EDSS: Expanded Disability Status Scale.
  7. DMDs: Disease Modifying Drugs.